Literature DB >> 17478007

Ceramic composites as matrices and scaffolds for drug delivery in tissue engineering.

W J E M Habraken1, J G C Wolke, J A Jansen.   

Abstract

Ceramic composites and scaffolds are popular implant materials in the field of dentistry, orthopedics and plastic surgery. For bone tissue engineering especially CaP-ceramics or cements and bioactive glass are suitable implant materials due to their osteoconductive properties. In this review the applicability of these ceramics but also of ceramic/polymer composites for bone tissue engineering is discussed, and in particular their use as drug delivery systems. Overall, the high density and slow biodegradability of ceramics is not beneficial for tissue engineering purposes. To address these issues, macroporosity can be introduced often in combination with osteoinductive growth factors and cells. Ceramics are good carriers for drugs, in which release patterns are strongly dependent on the chemical consistency of the ceramic, type of drug and drug loading. Biodegradable polymers like polylactic acid, gelatin or chitosan are used as matrices for ceramic particles or as adjuvant to calcium phosphate cements. The use of these polymers can introduce a tailored biodegradation/drug release to the ceramic material.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17478007     DOI: 10.1016/j.addr.2007.03.011

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  63 in total

Review 1.  Calcium phosphate ceramic systems in growth factor and drug delivery for bone tissue engineering: a review.

Authors:  Susmita Bose; Solaiman Tarafder
Journal:  Acta Biomater       Date:  2011-11-20       Impact factor: 8.947

Review 2.  Strategies for controlled delivery of growth factors and cells for bone regeneration.

Authors:  Tiffany N Vo; F Kurtis Kasper; Antonios G Mikos
Journal:  Adv Drug Deliv Rev       Date:  2012-02-04       Impact factor: 15.470

3.  The use of calcium phosphate-based biomaterials in implant dentistry.

Authors:  Cheng Xie; Hong Lu; Wei Li; Fa-Ming Chen; Yi-Min Zhao
Journal:  J Mater Sci Mater Med       Date:  2011-12-27       Impact factor: 3.896

4.  Synthesis of injectable and cohesive nano hydroxyapatite scaffolds.

Authors:  Nitin Pratap Varma; Subhadra Garai; Arvind Sinha
Journal:  J Mater Sci Mater Med       Date:  2012-03-16       Impact factor: 3.896

5.  Quantification of bone mass gain in response to the application of biphasic bioceramics and platelet concentrate in critical-size bone defects.

Authors:  Sonja Ellen Lobo; Francisco Henrique Lanna Wykrota; Ana Carolina Marques Barbosa Oliveira; Irina Kerkis; Germán Bohorquez Mahecha; Humberto José Alves
Journal:  J Mater Sci Mater Med       Date:  2008-12-27       Impact factor: 3.896

Review 6.  Evolving application of biomimetic nanostructured hydroxyapatite.

Authors:  Norberto Roveri; Michele Iafisco
Journal:  Nanotechnol Sci Appl       Date:  2010-11-09

Review 7.  [Bone tissue engineering in clinical application : assessment of the current situation].

Authors:  P Bernstein; M Bornhäuser; K-P Günther; M Stiehler
Journal:  Orthopade       Date:  2009-11       Impact factor: 1.087

Review 8.  Bone tissue engineering therapeutics: controlled drug delivery in three-dimensional scaffolds.

Authors:  Viviana Mouriño; Aldo R Boccaccini
Journal:  J R Soc Interface       Date:  2009-10-28       Impact factor: 4.118

Review 9.  The use of micro- and nanospheres as functional components for bone tissue regeneration.

Authors:  Huanan Wang; Sander C G Leeuwenburgh; Yubao Li; John A Jansen
Journal:  Tissue Eng Part B Rev       Date:  2011-09-23       Impact factor: 6.389

Review 10.  Perspectives on the role of nanotechnology in bone tissue engineering.

Authors:  Eduardo Saiz; Elizabeth A Zimmermann; Janice S Lee; Ulrike G K Wegst; Antoni P Tomsia
Journal:  Dent Mater       Date:  2012-08-14       Impact factor: 5.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.